These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3931959)

  • 1. Therapeutic management of cystic fibrosis.
    Kuhn RJ; Nahata MC
    Clin Pharm; 1985; 4(5):555-65. PubMed ID: 3931959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic management of cystic fibrosis.
    Wallace CS; Hall M; Kuhn RJ
    Clin Pharm; 1993 Sep; 12(9):657-74; quiz 700-1. PubMed ID: 8306566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic use in cystic fibrosis.
    Eisenberg JD
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary infections in children with cystic fibrosis.
    Stutman HR; Marks MI
    Semin Respir Infect; 1987 Sep; 2(3):166-76. PubMed ID: 3317617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cystic fibrosis--review].
    Jonsdottir B; Bergsteinsson H; Baldursson O
    Laeknabladid; 2008 Dec; 94(12):831-7. PubMed ID: 19182319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel therapeutic possibilities in cystic fibrosis].
    Kilian K; Kisiel BM
    Pol Merkur Lekarski; 2006 May; 20(119):586-90. PubMed ID: 16875169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic treatment of lung disease in cystic fibrosis].
    Biasini GC; Pistocchi E; Miano A
    Pediatr Med Chir; 1983; 5(4):157-60. PubMed ID: 6647075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
    O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
    Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled antimicrobial therapy: from cystic fibrosis to the flu.
    O'Riordan TG
    Respir Care; 2000 Jul; 45(7):836-45. PubMed ID: 10926381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation.
    Prescrire Int; 2002 Dec; 11(62):177-8. PubMed ID: 12469696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol antibiotics: considerations in pharmacological and clinical evaluation.
    Dudley MN; Loutit J; Griffith DC
    Curr Opin Biotechnol; 2008 Dec; 19(6):637-43. PubMed ID: 19036576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial infections and resistance to antibiotics in cystic fibrosis].
    Taccetti G; Repetto T; Procopio E; Marianelli L; Campana S
    Pediatr Med Chir; 1999; 21(5 Suppl):213-8. PubMed ID: 10963010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful meropenem desensitization in a patient with cystic fibrosis.
    Wilson DL; Owens RC; Zuckerman JB
    Ann Pharmacother; 2003 Oct; 37(10):1424-8. PubMed ID: 14519038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.